Should newborns be screened for immunodeficiency?: lessons learned from infants with recurrent otitis media

Yesim Yilmaz-Demirdag1

  • 1Department of Pediatrics, West Virginia University School of Medicine, Morgantown, USA. ydemirdag@hsc.wvu.edu

Insights

Recurrent ear infections in infants can signal severe combined immunodeficiency (SCID), a life-threatening condition. Early newborn screening for SCID is critical for timely treatment and improved survival rates.

Area of Science:

  • Pediatrics
  • Immunology
  • Genetics

Background:

  • Recurrent otitis media in children is a key indicator of primary immunodeficiencies (PIDs), especially antibody deficiencies.
  • Severe combined immunodeficiency (SCID), a critical pediatric emergency, can manifest with recurrent otitis media in infants.
  • SCID is a severe form of PID requiring immediate diagnosis and treatment for survival.

Purpose of the Study:

  • To highlight the importance of early diagnosis of SCID in infants presenting with recurrent otitis media.
  • To emphasize the critical window for intervention before severe infections occur.
  • To advocate for population-based newborn screening for SCID.

Main Methods:

  • Review of clinical presentations of primary immunodeficiencies, focusing on SCID.
  • Analysis of the impact of early diagnosis and treatment on SCID mortality rates.
  • Discussion of the role of otitis media as an early warning sign.

Main Results:

  • Delayed diagnosis of SCID often leads to severe, systemic infections and permanent health issues.
  • Mortality risk in SCID significantly decreases with immune reconstitution before 3.5 months of age.
  • Absence of newborn screening programs results in missed opportunities for early SCID detection and treatment.

Conclusions:

  • Early detection of SCID through newborn screening is paramount for preventing mortality and long-term sequelae.
  • Recurrent otitis media warrants thorough investigation for underlying immunodeficiencies like SCID.
  • Implementing universal newborn screening for SCID is essential for ensuring healthier lives for affected infants.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...